The Roche Diagnostics Elecsys Anti-HCV (hepatitis C virus) assay has now been approved for use in Europe for modular analytics and the e 601 module for the cobas 6000 platform. The assay is already available on the Elecsys 2010 and the cobas e 411 instruments. “The addition of anti-HCV assay to the E 170 analyser for modular analytics and the e 601 module for the cobas 6000 platform complements Roche’s already comprehensive menu of hepatitis immunodiagnostic and liver function assays, all of which can be accurately and simultaneously measured on a single blood sample to identify the underlying liver disorder,” the head of Roche Professional Diagnostics said.